PSCA is a target of chimeric antigen receptor T cells in gastric cancer
Abstract Background Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pa...
Saved in:
Main Authors: | Di Wu (Author), Jiang Lv (Author), Ruocong Zhao (Author), Zhiping Wu (Author), Diwei Zheng (Author), Jingxuan Shi (Author), Simiao Lin (Author), Suna Wang (Author), Qiting Wu (Author), Youguo Long (Author), Peng Li (Author), Yao Yao (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
by: Le Qin, et al.
Published: (2020) -
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
by: Wang M, et al.
Published: (2015) -
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
by: Xuejia Kang, et al.
Published: (2024) -
Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
by: Alejandrina Hernández-López, et al.
Published: (2021) -
Chimeric antigen receptor T cell therapy for multiple myeloma
by: Kana Hasegawa, et al.
Published: (2019)